Galderma Laboratories Release: Epiduo® TAP Program May Increase Patient Adherence to Acne Treatment
3/12/2013 9:36:26 AM
More...
|
Galderma Laboratories Release: Epiduo® Gel Becomes First Topical Prescription Acne Treatment Available for Children as Young as 9 Years Old
2/20/2013 9:25:00 AM
More...
|
FDA Approves Galderma Laboratories' Epiduo® to Treat Acne
2/19/2013 8:24:51 AM
More...
|
Galderma Laboratories's Tri-Luma® Cream, Only FDA-Approved Treatment for Melasma, Now Available in Pharmacies
2/12/2013 9:19:49 AM
More...
|
Ipsen (IPN.PA) and Galderma Laboratories Increase Their Collaboration for Dysport® in New Territories
12/3/2012 11:15:28 AM
More...
|
Fort Worth-Based Galderma Laboratories Pledges Additional $450,000 for Dermatology Program
8/7/2012 11:39:45 AM
More...
|
Galderma Laboratories Announces Completion of Phase 3 Trials of Investigational Drug Targeting Facial Erythema of Rosacea
3/16/2012 8:32:39 AM
More...
|
Galderma Laboratories Receives FDA Approval for New Convenient Pump Dispenser of Differin(R) Gel, 0.3% for Treatment of Acne Vulgaris
3/5/2012 8:12:06 AM
More...
|
Galderma Laboratories Announces Availability of New Metrogel(R) 1% Pump Dispenser for the Treatment of Papulopustular Rosacea
1/17/2012 9:20:16 AM
More...
|
#1 Branded Topical Acne Product, Epiduo(R) Gel of Galderma Laboratories, Receives FDA Approval for a New Convenient Pump Dispenser Third Rock Ventures
12/15/2011 8:46:02 AM
More...
|
|